天康生物
(002100)
| 流通市值：107.72亿 | | | 总市值：107.72亿 |
| 流通股本：13.65亿 | | | 总股本：13.65亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,534,658,402.03 | 2,830,800,392.93 | 2,080,650,501.44 | 3,778,630,042.58 |
| 交易性金融资产 | 361,954,389.06 | 426,280,026.99 | 349,973,574.63 | 130,804,873.91 |
| 衍生金融资产 | 4,479,680 | 159,222,040 | 56,493,320 | 83,675,220 |
| 应收票据及应收账款 | 565,645,231.13 | 628,110,844.38 | 450,048,009.86 | 650,780,595.49 |
| 其中：应收票据 | 12,659,795.95 | 7,568,349.49 | 6,256,592.46 | 43,114,698.84 |
| 应收账款 | 552,985,435.18 | 620,542,494.89 | 443,791,417.4 | 607,665,896.65 |
| 应收款项融资 | - | - | 170,000 | 14,027,810 |
| 预付款项 | 532,588,384.16 | 628,372,443.36 | 729,581,282.53 | 944,488,775.74 |
| 其他应收款合计 | 177,049,869.26 | 248,434,625.31 | 170,252,745.59 | 300,054,471.15 |
| 存货 | 4,323,142,042.07 | 5,345,121,891.67 | 5,565,452,646.59 | 3,067,743,989.93 |
| 其他流动资产 | 460,502,324.27 | 523,107,720.17 | 547,350,475.06 | 435,691,775.23 |
| 流动资产合计 | 8,960,020,321.98 | 10,789,449,984.81 | 9,949,972,555.7 | 9,405,897,554.03 |
| 非流动资产: | | | | |
| 长期股权投资 | 17,890,957.67 | 15,942,244.43 | 16,519,175.68 | 23,607,796.47 |
| 固定资产 | 7,485,977,484.68 | 5,494,477,030.08 | 5,621,161,711.95 | 5,654,051,247.05 |
| 在建工程 | 564,084,075.66 | 275,528,945.68 | 255,429,810.07 | 243,603,927.55 |
| 生产性生物资产 | 418,100,651.24 | 310,898,947.83 | 330,361,180.72 | 300,717,580.19 |
| 使用权资产 | 471,984,126.98 | 476,006,196.06 | 507,725,510.58 | 493,083,783.62 |
| 无形资产 | 361,903,390.28 | 362,341,624.01 | 363,784,479.46 | 362,831,749.28 |
| 开发支出 | 750,000 | 772,455.75 | 750,000 | 5,791,364.52 |
| 商誉 | 719,757,031.48 | 165,816,290.24 | 165,816,290.24 | 165,816,290.24 |
| 长期待摊费用 | 28,336,375.06 | 27,195,757.5 | 28,254,005.35 | 21,601,398.93 |
| 递延所得税资产 | 126,723,856.87 | 115,599,937.16 | 112,254,665.75 | 119,763,141.19 |
| 其他非流动资产 | 24,672,804 | 9,231,984 | 39,165,624.22 | 20,076,717.54 |
| 非流动资产合计 | 10,220,180,753.92 | 7,253,811,412.74 | 7,441,222,454.02 | 7,410,944,996.58 |
| 资产总计 | 19,180,201,075.9 | 18,043,261,397.55 | 17,391,195,009.72 | 16,816,842,550.61 |
| 流动负债: | | | | |
| 短期借款 | 2,150,983,883 | 2,859,605,224.49 | 3,113,591,224.68 | 2,225,002,284.81 |
| 衍生金融负债 | 10,651,920 | 8,642,580 | 157,600 | - |
| 应付票据及应付账款 | 784,122,949.86 | 714,831,830.27 | 601,576,925.83 | 648,604,160.24 |
| 其中：应付票据 | - | 198,415,860.4 | 103,063,912.5 | 6,687,280 |
| 应付账款 | 784,122,949.86 | 516,415,969.87 | 498,513,013.33 | 641,916,880.24 |
| 预收款项 | 32,624,255.85 | 1,172,913.84 | 1,250,446.85 | 115,836.71 |
| 合同负债 | 735,879,050.15 | 1,044,160,903.1 | 802,881,589.29 | 533,798,977.33 |
| 应付职工薪酬 | 176,467,524.42 | 196,892,732.47 | 172,982,233.25 | 234,812,343.45 |
| 应交税费 | 12,093,295.32 | 31,544,809.74 | 19,960,261.06 | 23,453,642.17 |
| 其他应付款合计 | 1,966,381,364.15 | 732,377,610.39 | 611,048,648.76 | 680,186,135.3 |
| 应付股利 | 697,401,788.29 | - | - | - |
| 一年内到期的非流动负债 | 899,806,961.65 | 922,206,174.42 | 1,066,029,859.41 | 1,009,824,580.92 |
| 其他流动负债 | 87,578,290.93 | 92,293,329.26 | 105,309,844.05 | 78,744,143.15 |
| 流动负债合计 | 6,856,589,495.33 | 6,603,728,107.98 | 6,494,788,633.18 | 5,434,542,104.08 |
| 非流动负债: | | | | |
| 长期借款 | 3,139,777,413.48 | 2,551,527,549.25 | 1,875,527,549.25 | 2,160,540,457.25 |
| 租赁负债 | 342,915,651.1 | 278,087,266.16 | 313,037,886.48 | 290,380,457.94 |
| 长期应付款 | 50,000,000 | - | - | - |
| 预计负债 | 94,469.02 | 94,469.02 | 94,469.02 | 94,469.02 |
| 递延收益 | 252,887,299.13 | 150,434,962.74 | 152,942,604.53 | 146,280,207.14 |
| 递延所得税负债 | 13,870,540.22 | 17,681,956.57 | 18,083,526.74 | 17,527,635.91 |
| 非流动负债合计 | 3,799,545,372.95 | 2,997,826,203.74 | 2,359,686,036.02 | 2,614,823,227.26 |
| 负债合计 | 10,656,134,868.28 | 9,601,554,311.72 | 8,854,474,669.2 | 8,049,365,331.34 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,365,251,515 | 1,365,251,515 | 1,365,251,515 | 1,365,251,515 |
| 资本公积 | 3,945,016,200.81 | 3,945,016,200.81 | 3,945,016,200.81 | 3,942,914,792.29 |
| 其他综合收益 | 12,492,165.83 | 144,628,049.14 | 63,654,410.74 | 93,791,557.2 |
| 盈余公积 | 466,773,396.09 | 466,773,396.09 | 466,773,396.09 | 466,773,396.09 |
| 一般风险准备 | 3,854,383.76 | 3,854,383.76 | 3,854,383.76 | 3,854,383.76 |
| 未分配利润 | 548,768,173.99 | 933,444,182.37 | 1,096,726,025.23 | 1,297,840,636.07 |
| 归属于母公司股东权益合计 | 6,342,155,835.48 | 6,858,967,727.17 | 6,941,275,931.63 | 7,170,426,280.41 |
| 少数股东权益 | 2,181,910,372.14 | 1,582,739,358.66 | 1,595,444,408.89 | 1,597,050,938.86 |
| 股东权益合计 | 8,524,066,207.62 | 8,441,707,085.83 | 8,536,720,340.52 | 8,767,477,219.27 |
| 负债和股东权益合计 | 19,180,201,075.9 | 18,043,261,397.55 | 17,391,195,009.72 | 16,816,842,550.61 |
| 公告日期 | 2026-08-27 | 2026-04-30 | 2026-04-29 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |